Bericht
Guidelines on patentability and access to medicines
Until recently, the link between the examination of patents carried out by national patent offices and the right of citizens to access to medicines was not at all clear. They were two functions or responsibilities of the State that apparently had nothing to do with each other. Examining the growing literature on intellectual property and access to medicines, it seems that the analysis of one actor has been left out: the patent offices. And the reason is clear: patent offices are administrative institutions. Patentability requirements are not defined by patent offices, but frequently by the courts, tribunals, legislation or treaty negotiators. There is now greater understanding that the examination of patents and the role played by patent examiners are key elements that could contribute to or obstruct access to medicines. Given the impact of pharmaceutical patents on access to medicines, patent offices should draw up public policies and strategies that respond to national health and medicine policies.
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 61
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Thema
-
Immaterialgüterrechte
Arzneimittel
Internationales Patentrecht
TRIPS
Welt
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Velásquez, Germán
- Ereignis
-
Veröffentlichung
- (wer)
-
South Centre
- (wo)
-
Geneva
- (wann)
-
2015
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:43 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Velásquez, Germán
- South Centre
Entstanden
- 2015
Ähnliche Objekte (12)
Intellectual property, public health and access to medicines in international organizations
Access to medicines and intellectual property: The contribution of the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Intellectual property, public health and access to medicines in international organizations
Access to medicines and intellectual property: The contribution of the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Intellectual property, public health and access to medicines in international organizations
Access to medicines and intellectual property: The contribution of the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community